Novel-D3 Vitamin D3 Oral Solution

Manufacturer
Novel Pack LLC
Effective date
2022-04-30
Label type
Dietary Supplement
Version
1
Source
full-release
Hydrated at
2026-06-01 02:50:27

Label at a glance#

ProductNovel-D3
Active ingredientCHOLECALCIFEROL
Label structure5 sections

Label contents#

Full prescribing information#

Statement of Identity section

Vitamin D3 Oral Solution 60000IU/5ml

Dosage

DOSAGE & ADMINISTRATION SECTION

As directed by the Physician

SAFE HANDLING WARNING SECTION

Store at a temperature not exceeding 25°C.

Protect from direct sunlight

WARNINGS SECTION

Keep out of reach of children

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Box LabelBox Label

Container LabelContainer Label

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CHOLECALCIFEROL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
60c52429-fcef-eb54-2387-43bc9e4f296bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82489-111-01Novel-D34 in 1 CARTONSOLUTION41

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82489-111NOVEL-D3 (VITAMIN D3) SOLUTION [NOVEL PACK LLC]11 package rows20220506_83b30e91-8960-4cdf-b38f-b5e88709e93d.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82489-11182489-111-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
CHOLECALCIFEROL1C6V77QF41ACTIB

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.